It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The extravillous trophoblast cell lineage is a key feature of placentation and successful pregnancy. Knowledge of transcriptional regulation driving extravillous trophoblast cell development is limited. Here, we map the transcriptome and epigenome landscape as well as chromatin interactions of human trophoblast stem cells and their transition into extravillous trophoblast cells. We show that integrating chromatin accessibility, long-range chromatin interactions, transcriptomic, and transcription factor binding motif enrichment enables identification of transcription factors and regulatory mechanisms critical for extravillous trophoblast cell development. We elucidate functional roles for TFAP2C, SNAI1, and EPAS1 in the regulation of extravillous trophoblast cell development. EPAS1 is identified as an upstream regulator of key extravillous trophoblast cell transcription factors, including ASCL2 and SNAI1 and together with its target genes, is linked to pregnancy loss and birth weight. Collectively, we reveal activation of a dynamic regulatory network and provide a framework for understanding extravillous trophoblast cell specification in trophoblast cell lineage development and human placentation.
Invasive extravillous trophoblast cells are a key feature of placentation and successful pregnancy. Here, the authors identify transcription factors and regulatory mechanisms critical for extravillous trophoblast cell lineage development.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 University of Kansas Medical Center, Institute for Reproductive and Developmental Sciences, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375); University of Kansas Medical Center, Department of Pathology & Laboratory Medicine, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375)
2 Children’s Mercy Kansas City, Genomic Medicine Center, Children’s Mercy Research Institute, Kansas City, USA (GRID:grid.512054.7)
3 Stowers Institute for Medical Research, Kansas City, USA (GRID:grid.250820.d) (ISNI:0000 0000 9420 1591)
4 University of Kansas Medical Center, Institute for Reproductive and Developmental Sciences, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375); University of Kansas Medical Center, Department of Pathology & Laboratory Medicine, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375); Northwestern University Feinberg School of Medicine, Department of Obstetrics and Gynecology, Chicago, USA (GRID:grid.16753.36) (ISNI:0000 0001 2299 3507)
5 Tohoku University Graduate School of Medicine, Department of Informative Genetics, Environment and Genome Research Center, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943); Kumamoto University, Department of Trophoblast Research, Institute of Molecular Embryology and Genetics, Kumamoto, Japan (GRID:grid.274841.c) (ISNI:0000 0001 0660 6749)
6 Tohoku University Graduate School of Medicine, Department of Informative Genetics, Environment and Genome Research Center, Sendai, Japan (GRID:grid.69566.3a) (ISNI:0000 0001 2248 6943)
7 University of Kansas Medical Center, Department of Obstetrics and Gynecology, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375)
8 University of Kansas Medical Center, Institute for Reproductive and Developmental Sciences, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375); University of Kansas Medical Center, Department of Obstetrics and Gynecology, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375)
9 University of Kansas Medical Center, Institute for Reproductive and Developmental Sciences, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375); University of Kansas Medical Center, Department of Pathology & Laboratory Medicine, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375); University of Kansas Medical Center, Department of Obstetrics and Gynecology, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375); Children’s Mercy Kansas City, Center for Perinatal Research, Children’s Mercy Research Institute, Kansas City, USA (GRID:grid.512054.7)
10 University of Kansas Medical Center, Institute for Reproductive and Developmental Sciences, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375); University of Kansas Medical Center, Department of Pathology & Laboratory Medicine, Kansas City, USA (GRID:grid.412016.0) (ISNI:0000 0001 2177 6375); Children’s Mercy Kansas City, Genomic Medicine Center, Children’s Mercy Research Institute, Kansas City, USA (GRID:grid.512054.7)